Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials
2022 · BMC Cancer · 37 citations
https://doi.org/10.1186/s12885-022-09444-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
515
Citations
10
h-index
12
i10-index
Hong Zhao is an academic researcher from Tianjin Medical University Eye Hospital. The author has contributed to research in topics: Nasolacrimal Duct Obstruction Treatments & Salivary Gland Tumors Diagnosis and Treatment & Ocular Oncology and Treatments. The author has an h-index of 10, co-authored 39 publications.
ORCID: 0000-0002-8984-2188https://doi.org/10.1186/s12885-022-09444-0
https://doi.org/10.1186/s13018-023-03818-1
Click to start Chat